Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
DCOY
DCOY
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
DCOY News
Universe Pharma Acquires Patent Portfolio, Shares Surge
Jun 30 2026
NASDAQ.COM
Decoy Therapeutics Secures $3.5 Million Funding
Jun 29 2026
stocktwits
Universe Pharmaceuticals Acquires Best Praise International
Jun 29 2026
Newsfilter
Decoy Therapeutics Secures $3.5M PIPE Financing to Advance Antiviral Candidate
Jun 29 2026
seekingalpha
Decoy Therapeutics Secures $3.5 Million PIPE Financing
Jun 29 2026
NASDAQ.COM
Decoy Therapeutics Secures $3.5 Million PIPE Financing
Jun 27 2026
PRnewswire
Decoy Therapeutics Secures $3.5 Million PIPE Financing
Jun 27 2026
Newsfilter
Decoy Therapeutics Nominates New Director
Jun 03 2026
PRnewswire
Decoy Therapeutics Partners with hVIVO for D-MAV Clinical Development
Jun 01 2026
NASDAQ.COM
Decoy Therapeutics Initiates Clinical Studies for New Antiviral Category
Jun 01 2026
PRnewswire
Decoy Appoints New Chair of Scientific Advisory Board
May 26 2026
PRnewswire
Biotech Stocks Surge with Akari Leading the Rally
May 26 2026
NASDAQ.COM
Decoy Therapeutics Showcases Novel Antiviral Therapies in Boston
Apr 27 2026
PRnewswire
Decoy Therapeutics Launches Multi-Virus Antiviral Platform
Apr 09 2026
PRnewswire
Decoy Therapeutics Launches Multi-Viral Antiviral Platform
Apr 09 2026
Newsfilter
Decoy Therapeutics CEO to Participate in Investor Event
Apr 06 2026
PRnewswire
Show More News